re: WSJ: Why Is the FDA Attacking a Safe, Effective Drug?

It’s not an opinion article. It’s an editorial where they state facts in support of a drug and question why it’s being vilified without proof.

Also:
Mr. Henderson, a research fellow with the Hoover Institution at Stanford University, was senior health economist with President Reagan’s Council of Economic Advisers. Mr. Hooper is president of Objective Insights, a firm that consults with pharmaceutical clients.